跳转至内容
Merck
CN

MAB1302

小鼠抗人IgG抗体,克隆HP6017,Fc

clone HP6017, Chemicon®, from mouse

别名:

Anti-CD32, Anti-CD32B, Anti-FCG2, Anti-FCGR2, Anti-FCGR2C, Anti-FcGRIIB, Anti-FcRII-c, Anti-FcgammaRIIb, Anti-IGFR2

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
12352203
NACRES:
NA.46
eCl@ss:
32160702
Clone:
HP6017, monoclonal
Species reactivity:
human
Application:
ELISA, RIA, WB
Citations:
3
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

biological source

mouse

antibody form

purified immunoglobulin

antibody product type

secondary antibodies

clone

HP6017, monoclonal

species reactivity

human

manufacturer/tradename

Chemicon®

technique(s)

ELISA: suitable, radioimmunoassay: suitable, western blot: suitable

isotype

IgG2aκ

UniProt accession no.

shipped in

wet ice

target post-translational modification

unmodified

Quality Level

Gene Information

human ... FCGR2B(2213)

Immunogen

表位:Fc片段

Application

使用经验证可用于ELISA、RIA &WB的小鼠抗人IgG抗体,克隆HP6017,Fc检测人IgG。
可用作人IgG Fc的捕获抗体和检测抗体(Papadea et al., 1985; Hamilton, et al., 1987)。

ELISA

放射免疫测定(RIA)

免疫印迹。

最佳工作稀释度必须由最终用户进行确定。
研究子类别
片段特异性二抗
研究类别
二抗&对照抗体

Biochem/physiol Actions

人 IgG Fc 片段。ELISA特异性:(Hamilton et al.,1987)

人IgG亚类1 100%

人IgG 亚类2 100%

人IgG 亚类3 100%

人IgG亚类 4 100%

人IgG Pan 100%

人IgG Fc 100%

人IgG Fab .12%



等电聚焦: 平均pI8.0

Physical form

形式:纯化
纯化的免疫球蛋白。 0.02 M PB,0.25 M NaCl,含0.1%叠氮化钠,pH=7.6中的液体。

Preparation Note

以未稀释的等分试样保存于2-8°C下12个月。

Other Notes

替代品:CBL102
浓度:请参考批次特异性浓缩物的分析证书。

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。

未找到合适的产品?  

试试我们的产品选型工具.

存储类别

10 - Combustible liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Miguel Ángel Muñoz-Alía et al.
PLoS pathogens, 17(2), e1009283-e1009283 (2021-02-04)
The frequent overexpression of CD46 in malignant tumors has provided a basis to use vaccine-lineage measles virus (MeV) as an oncolytic virotherapy platform. However, widespread measles seropositivity limits the systemic deployment of oncolytic MeV for the treatment of metastatic neoplasia.
Gunnveig Grodeland et al.
Journal of immunology (Baltimore, Md. : 1950), 197(9), 3575-3585 (2016-09-28)
It has been difficult to translate promising results from DNA vaccination in mice to larger animals and humans. Previously, DNA vaccines encoding proteins that target Ag to MHC class II (MHC-II) molecules on APCs have been shown to induce rapid
Kartik A Shah et al.
Biotechnology and bioengineering, 112(12), 2624-2629 (2015-06-03)
Monoclonal antibodies (mAbs) that bind and neutralize human pathogens have great therapeutic potential. Advances in automated screening and liquid handling have resulted in the ability to discover antigen-specific antibodies either directly from human blood or from various combinatorial libraries (phage

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持